Magnitude of [11C]PK11195 Binding Is Related to Severity of Motor Deficits in a Rabbit Model of Cerebral Palsy Induced by Intrauterine Endotoxin Exposure

Intrauterine inflammation is known to be a risk factor for the development of periventricular leukomalacia (PVL) and cerebral palsy. In recent years, activated microglial cells have been implicated in the pathogenesis of PVL and in the development of white matter injury. Clinical studies have shown the increased presence of activated microglial cells diffusely throughout the white matter in brains of patients with PVL. In vitro studies have reported that activated microglial cells induce oligodendrocyte damage and white matter injury by release of inflammatory cytokines, reactive nitrogen and oxygen species and the production of excitotoxic metabolites. PK11195 [1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinoline carboxamide] is a ligand that is selective for the 18-kDa translocator protein expressed on the outer mitochondrial membrane of activated microglia and macrophages. When labeled with carbon-11, [11C]PK11195 can effectively be used as a ligand in positron emission tomography (PET) studies for the detection of activated microglial cells in various neuroinflammatory and neurodegenerative conditions. In this study, we hypothesized that the magnitude of [11C]-(R)-PK11195 uptake in the newborn rabbit brain, as measured using a small-animal PET scanner, would match the severity of motor deficits resulting from intrauterine inflammation-induced perinatal brain injury. Pregnant New Zealand white rabbits were intrauterinely injected with endotoxin or saline at 28 days of gestation. Kits were born spontaneously at 31 days and underwent neurobehavioral testing and PET imaging following intravenous injection of the tracer [11C]-(R)-PK11195 on the day of birth. The neurobehavioral scores were compared with the change in [11C]PK11195 uptake over the time of scanning, for each of the kits. Upon analysis using receiver operating characteristic curves, an optimal combined sensitivity and specificity for detecting abnormal neurobehavioral scores suggestive of cerebral palsy in the neonatal rabbit was noted for a positive change in [11C]PK11195 uptake in the brain over time on PET imaging (sensitivity of 100% and area under the curve of >0.82 for all parameters tested). The strongest agreements were noted between a positive uptake slope – indicating increased [11C]PK11195 uptake over time – and worsening scores for measures of locomotion (indicated by hindlimb movement, forelimb movement, circular motion and straight- line motion; Cohen’s ĸ >0.75 for each) and feeding (indicated by ability to suck and swallow and turn the head during feeding; Cohen’s ĸ >0.85 for each). This was also associated with increased numbers of activated microglia (mean ratio ± SD of activated to total microglia: 0.96 ± 0.16 in the endotoxin group vs. 0.13 ± 0.08 in controls; p < 0.001) in the internal capsule and corona radiata. Our findings indicate that the magnitude of [11C]PK11195 binding measured in vivo by PET imaging matches the severity of motor deficits in the neonatal rabbit. Molecular imaging of ongoing neuroinflammation in the neonatal period may be helpful as a screening biomarker for detecting patients at risk of developing cerebral palsy due to a perinatal insult.

[1]  D. Brenner,et al.  Computed tomography--an increasing source of radiation exposure. , 2007, The New England journal of medicine.

[2]  K. Pahan,et al.  Up-regulation of Microglial CD11b Expression by Nitric Oxide* , 2006, Journal of Biological Chemistry.

[3]  D. Perani,et al.  Faculty Opinions recommendation of Microglial activation and amyloid deposition in mild cognitive impairment: a PET study. , 2009 .

[4]  R B Banati,et al.  The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. , 2000, Brain : a journal of neurology.

[5]  J. Morgan,et al.  Benzodiazepines that bind at peripheral sites inhibit cell proliferation. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[6]  D. Attwell,et al.  NMDA receptors are expressed in oligodendrocytes and activated in ischaemia , 2005, Nature.

[7]  Mari Yoshida,et al.  Cytokine production of activated microglia and decrease in neurotrophic factors of neurons in the hippocampus of Lewy body disease brains , 2005, Acta Neuropathologica.

[8]  H. Kinney,et al.  Development of microglia in the cerebral white matter of the human fetus and infant , 2006, The Journal of comparative neurology.

[9]  Matthew Derrick,et al.  Preterm Fetal Hypoxia-Ischemia Causes Hypertonia and Motor Deficits in the Neonatal Rabbit: A Model for Human Cerebral Palsy? , 2004, The Journal of Neuroscience.

[10]  J. Hirsch,et al.  Mitochondrial benzodiazepine receptors mediate inhibition of mitochondrial respiratory control. , 1989, Molecular pharmacology.

[11]  L. Rome,et al.  Stimulation of in vitro myelin synthesis by microglia , 1994, Glia.

[12]  R B Banati,et al.  In vivo visualization of activated glia by [11C] (R)-PK11195-PET following herpes encephalitis reveals projected neuronal damage beyond the primary focal lesion. , 2001, Brain : a journal of neurology.

[13]  B. Lopresti,et al.  The peripheral benzodiazepine receptor (Translocator protein 18kDa) in microglia: From pathology to imaging , 2006, Progress in Neurobiology.

[14]  Y. Pang,et al.  Cytokine Induction in Fetal Rat Brains and Brain Injury in Neonatal Rats after Maternal Lipopolysaccharide Administration , 2000, Pediatric Research.

[15]  M. Wirenfeldt,et al.  Microglial cell population dynamics in the injured adult central nervous system , 2005, Brain Research Reviews.

[16]  Jessica K. Alexander,et al.  Identification of Two Distinct Macrophage Subsets with Divergent Effects Causing either Neurotoxicity or Regeneration in the Injured Mouse Spinal Cord , 2009, The Journal of Neuroscience.

[17]  J. Hallenbeck,et al.  Effects of intrauterine inflammation on developing rat brain , 2002, Journal of neuroscience research.

[18]  V. Papadopoulos,et al.  In vivo studies on the role of the peripheral benzodiazepine receptor (PBR) in steroidogenesis. , 1998, Endocrine research.

[19]  O. Dammann,et al.  Fetal Inflammatory Response and Brain Injury in the Preterm Newborn , 2009, Journal of child neurology.

[20]  D. Peebles,et al.  Models of white matter injury: comparison of infectious, hypoxic-ischemic, and excitotoxic insults. , 2002, Mental retardation and developmental disabilities research reviews.

[21]  Martin Rossor,et al.  Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study , 2008, Neurobiology of Disease.

[22]  R. Boellaard,et al.  Microglia Activation in Recent-Onset Schizophrenia: A Quantitative (R)-[11C]PK11195 Positron Emission Tomography Study , 2008, Biological Psychiatry.

[23]  H. Kinney,et al.  Nitrosative and Oxidative Injury to Premyelinating Oligodendrocytes in Periventricular Leukomalacia , 2003, Journal of neuropathology and experimental neurology.

[24]  C. Pert,et al.  Benzodiazepine receptor-mediated chemotaxis of human monocytes. , 1985, Science.

[25]  G. Kollias,et al.  Apoptosis of Oligodendrocytes via Fas and TNF-R1 Is a Key Event in the Induction of Experimental Autoimmune Encephalomyelitis1 , 2005, The Journal of Immunology.

[26]  S. Jander,et al.  The role of microglia and macrophages in the pathophysiology of the CNS , 1999, Progress in Neurobiology.

[27]  T. Guilarte,et al.  Cellular and Subcellular Localization of Peripheral Benzodiazepine Receptors After Trimethyltin Neurotoxicity , 2000, Journal of neurochemistry.

[28]  A. Michelucci,et al.  Characterization of the microglial phenotype under specific pro-inflammatory and anti-inflammatory conditions: Effects of oligomeric and fibrillar amyloid-β , 2009, Journal of Neuroimmunology.

[29]  Axonal sprouting and laminin appearance after destruction of glial sheaths. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[30]  T. Guilarte,et al.  Peripheral benzodiazepine receptor imaging in CNS demyelination: functional implications of anatomical and cellular localization. , 2004, Brain : a journal of neurology.

[31]  I. Duncan,et al.  Reactive microglia in dysmyelination and demyelination , 2001, Glia.

[32]  F E Turkheimer,et al.  [11C](R)-PK11195 positron emission tomography imaging of activated microglia in vivo in Rasmussen’s encephalitis , 1999, Neurology.

[33]  O. Muzik,et al.  Microglial Activation in Perinatal Rabbit Brain Induced by Intrauterine Inflammation: Detection with 11C-(R)-PK11195 and Small-Animal PET , 2007, Journal of Nuclear Medicine.

[34]  R. Banati,et al.  Visualising microglial activation in vivo , 2002, Glia.

[35]  F. Aloisi,et al.  The role of microglia and astrocytes in CNS immune surveillance and immunopathology. , 1999, Advances in experimental medicine and biology.

[36]  T. Guilarte,et al.  Imaging the peripheral benzodiazepine receptor response in central nervous system demyelination and remyelination. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[37]  D. Broga,et al.  Ionizing Radiation Exposure of the Population of the United States , 2009 .

[38]  J. Volpe,et al.  Peroxynitrite generated by inducible nitric oxide synthase and NADPH oxidase mediates microglial toxicity to oligodendrocytes. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[39]  R. Romero,et al.  Fetal exposure to an intra-amniotic inflammation and the development of cerebral palsy at the age of three years. , 2000, American journal of obstetrics and gynecology.

[40]  S. Snyder,et al.  Isolation of the mitochondrial benzodiazepine receptor: association with the voltage-dependent anion channel and the adenine nucleotide carrier. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[41]  C. Colton,et al.  Activated human microglia produce the excitotoxin quinolinic acid , 1997, Neuroreport.

[42]  P. Gressens,et al.  Microglial MyD88 signaling regulates acute neuronal toxicity of LPS-stimulated microglia in vitro , 2010, Brain, Behavior, and Immunity.

[43]  J. R. Landis,et al.  The measurement of observer agreement for categorical data. , 1977, Biometrics.

[44]  Shijie Jin,et al.  Glutamate induces neurotrophic factor production from microglia via protein kinase C pathway , 2010, Brain Research.

[45]  N. Takei,et al.  Production of basic fibroblast growth factor in cultured rat brain microglia , 1991, Neuroscience Letters.

[46]  Alexander Hammers,et al.  In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease , 2006, Neurobiology of Disease.

[47]  R B Banati,et al.  [11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy , 2003, Neurology.

[48]  S. Barger,et al.  Glutamate release from activated microglia requires the oxidative burst and lipid peroxidation , 2007, Journal of neurochemistry.

[49]  T. Marunouchi,et al.  Production of tumor necrosis factor-alpha by microglia and astrocytes in culture , 1989, Brain Research.

[50]  F. Zavala,et al.  In vivo immunomodulating activity of PK 1195, a structurally unrelated ligand for "peripheral" benzodiazepine binding sites--I. Potentiation in mice of the humoral response to sheep red blood cells. , 1986, International journal of immunopharmacology.

[51]  Gabriel J Escobar,et al.  Chorioamnionitis and cerebral palsy in term and near-term infants. , 2003, JAMA.

[52]  James Janisse,et al.  Intrauterine administration of endotoxin leads to motor deficits in a rabbit model: a link between prenatal infection and cerebral palsy. , 2008, American journal of obstetrics and gynecology.